Trends in Transcatheter Aortic Valve Implantation Utilization, Outcomes, and Healthcare Resource Use in Patients With Liver Cirrhosis: A Decade of Insights (2011-2020).
| Autor: | Krittanawong C; From the Cardiology Division, NYU Langone Health and NYU School of Medicine, New York, NY., Wang Y; Mercy Internal Medicine Service, Trinity Health of New England, Springfield, MA., Qadeer YK; Section of Cardiology, Baylor College of Medicine, Houston, TX., Chen B; Department of Gastroenterology and Nutrition, Geisinger Medical Center, Danville, PA., Wang Z; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.; Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, MN., Al-Azzam F; Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota., Alam M; The Texas Heart Institute, Baylor College of Medicine, Houston, TX., Sharma S; Cardiac Catheterization Laboratory of the Cardiovascular Institute, Mount Sinai Hospital, New York, NY., Jneid H; John Sealy Distinguished Centennial Chair in Cardiology, Chief, Division of Cardiology, University of Texas Medical Branch, Houston, TX. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Critical pathways in cardiology [Crit Pathw Cardiol] 2024 Sep 01; Vol. 23 (3), pp. 166-173. Date of Electronic Publication: 2024 Apr 09. |
| DOI: | 10.1097/HPC.0000000000000361 |
| Abstrakt: | It is well known that individuals with liver cirrhosis are considered at high risk for cardiac surgery, with an increased risk for morbidity and mortality as the liver disease progresses. In the last decade, there have been considerable advances in transcatheter aortic valve implantation (TAVI) as an alternative to surgical aortic valve replacement (SAVR) in individuals deemed to be at high risk for surgery. However, research surrounding TAVI in the setting of liver cirrhosis has not been as widely studied. In this national population-based cohort study, we evaluated the trends of mortality, complications, and healthcare utilization in liver cirrhotic patients undergoing TAVI, as well as analyzed the basic demographics of these individuals. We found that from 2011 to 2020, the amount of TAVI procedures conducted in cirrhotic patients was increasing annually, while mortality, procedural complications, and healthcare utilization trends in these cirrhotic patients undergoing TAVI decreased. Overall, TAVI does seem to be reasonable management for aortic stenosis patients with liver cirrhosis who need aortic valve replacement. (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|